Prospective evaluation of an index for predicting the risk of major bleeding in outpatients treated with warfarin (Q77199911)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9727814%20AND%20SRC:MED&resulttype=core&format=json

3 December 2019

title

Prospective evaluation of an index for predicting the risk of major bleeding in outpatients treated with warfarin (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9727814%20AND%20SRC:MED&resulttype=core&format=json

3 December 2019

1 reference

R J Beyth

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9727814%20AND%20SRC:MED&resulttype=core&format=json

3 December 2019

L M Quinn

series ordinal

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9727814%20AND%20SRC:MED&resulttype=core&format=json

3 December 2019

C S Landefeld

series ordinal

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9727814%20AND%20SRC:MED&resulttype=core&format=json

3 December 2019

publication date

1 August 1998

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9727814%20AND%20SRC:MED&resulttype=core&format=json

American Journal of Medicine

3 December 2019

published in

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9727814%20AND%20SRC:MED&resulttype=core&format=json

3 December 2019

volume

105

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9727814%20AND%20SRC:MED&resulttype=core&format=json

3 December 2019

page(s)

91-99

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9727814%20AND%20SRC:MED&resulttype=core&format=json

3 December 2019

issue

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9727814%20AND%20SRC:MED&resulttype=core&format=json

The effect of low-dose warfarin on the risk of stroke in patients with nonrheumatic atrial fibrillation

3 December 2019

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2898%2900198-3

Prevention of venous thromboembolism

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2898%2900198-3

Canadian atrial fibrillation anticoaguiation (CAFA) study

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2898%2900198-3

Warfarin in the prevention of stroke associated with nonrheumatic atrial fibrillation. Veterans Affairs Stroke Prevention in Nonrheumatic Atrial Fibrillation Investigators

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2898%2900198-3

Placebo-controlled, randomised trial of warfarin and aspirin for prevention of thromboembolic complications in chronic atrial fibrillation. The Copenhagen AFASAK study.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2898%2900198-3

Trial of different intensities of anticoagulation in patients with prosthetic heart valves.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2898%2900198-3

The effect of warfarin on mortality and reinfarction after myocardial infarction

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2898%2900198-3

Stroke Prevention in Atrial Fibrillation Study. Final results

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2898%2900198-3

Failure to prescribe warfarin to patients with nonrheumatic atrial fibrillation

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2898%2900198-3

Why isn't warfarin prescribed to patients with nonrheumatic atrial fibrillation?

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2898%2900198-3

Physician variation in anticoagulating patients with atrial fibrillation. Dartmouth Primary Care COOP Project

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2898%2900198-3

Factors relevant to preventing embolic stroke in patients with non-rheumatic atrial fibrillation.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2898%2900198-3

Physicians' attitudes toward oral anticoagulants and antiplatelet agents for stroke prevention in elderly patients with atrial fibrillation

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2898%2900198-3

Physician attitudes about anticoagulation for nonvalvular atrial fibrillation in the elderly

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2898%2900198-3

Anticoagulant therapy in cerebral infarction. Report on cooperative study.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2898%2900198-3

Risk factors for complications of chronic anticoagulation. A multicenter study. Warfarin Optimized Outpatient Follow-up Study Group

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2898%2900198-3

Identification and preliminary validation of predictors of major bleeding in hospitalized patients starting anticoagulant therapy

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2898%2900198-3

Major bleeding in outpatients treated with warfarin: incidence and prediction by factors known at the start of outpatient therapy

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2898%2900198-3

Bleeding complications to oral anticoagulant therapy: multivariate analysis of 1010 treatment years in 551 outpatients

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2898%2900198-3

Haemorrhagic and thromboembolic complications in patients with atrial fibrillation on anticoagulant prophylaxis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2898%2900198-3

Problems associated with long-term anticoagulant therapy. Observations in 139 cases

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2898%2900198-3

A bleeding risk index for estimating the probability of major bleeding in hospitalized patients starting anticoagulant therapy

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2898%2900198-3

The bleeding severity index: validation and comparison to other methods for classifying bleeding complications of medical therapy

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2898%2900198-3

Evaluating the yield of medical tests

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2898%2900198-3

Multivariable prognostic models: issues in developing models, evaluating assumptions and adequacy, and measuring and reducing errors

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2898%2900198-3

Predicting clinical states in individual patients

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2898%2900198-3

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2898%2900198-3

The risk for and severity of bleeding complications in elderly patients treated with warfarin. The National Consortium of Anticoagulation Clinics

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2898%2900198-3

Bleeding complications of oral anticoagulant treatment: an inception-cohort, prospective collaborative study (ISCOAT). Italian Study on Complications of Oral Anticoagulant Therapy

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2898%2900198-3

Duration of warfarin anticoagulant therapy and the probabilities of recurrent thromboembolism and hemorrhage

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2898%2900198-3

An evaluation of anticoagulant therapy in the treatment of cerebrovascular disease. Report of the Veterans Administration Cooperative Study of Atherosclerosis, Neruology Section

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2898%2900198-3

Therapeutic level in long term anticoagulant therapy after myocardial infarction. Its relation to recurrent infarction and sudden death

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2898%2900198-3

Anticoagulant therapy in cerebral thrombosis and cerebral embolism. A national cooperative study, interim report

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2898%2900198-3

Users' Guides to the Medical Literature

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2898%2900198-3

Aging and the anticoagulant response to warfarin therapy

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2898%2900198-3

Bleeding in outpatients treated with warfarin: relation to the prothrombin time and important remediable lesions.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2898%2900198-3

10.1016/S0002-9343(98)00198-3

7 January 2021

Identifiers

DOI

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9727814%20AND%20SRC:MED&resulttype=core&format=json

3 December 2019

1 reference